The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide injection, which is currently in shortage and sold under the brand name Victoza, will provide a low-cost option for those who need GLP-1…
Source link
Welcome to WikipediaNews.com, your premier destination for a diverse range of news categories! Here, we bring you the latest updates and insights from various fields, including technology, culture, science, and more, all inspired by the collaborative spirit of Wikipedia. Whether you're looking for breaking news, in-depth analysis, or trending topics, we’ve got something for everyone. Stay informed and engaged with the ever-evolving world of knowledge!
wikipedianews.com
© Copyright - WikipediaNews.com
